US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 106.130
  • 0.0000.00%
Close Nov 27 16:00 ET
  • 105.900
  • -0.230-0.22%
Post 18:52 ET
472.93BMarket Cap35.59P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.04%43.85B
76.73%50.5B
-51.99%14.31B
38.06%108.91B
34.50%9.55B
69.01%40.97B
19.26%28.58B
26.41%29.81B
43.43%78.89B
335.37%7.1B
Net income from continuing operations
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Operating gains losses
----
----
----
66.39%32.27B
----
----
----
----
19.23%19.39B
----
Depreciation and amortization
-14.85%2.15B
306.29%8.85B
69.52%2.91B
27.86%9.41B
47.03%2.99B
23.71%2.53B
33.07%2.18B
4.18%1.72B
22.19%7.36B
-2.26%2.04B
Deferred tax
26.82%7.08B
9.45%5.28B
32.26%6.51B
55.06%20.99B
107.67%5.66B
53.98%5.59B
38.80%4.83B
32.73%4.92B
19.55%13.54B
22.65%2.72B
Other non cash items
846.75%18.81B
4.43%11.18B
-99.42%118M
-247.68%-2.04B
-27.91%-34.96B
-88.24%1.99B
142.36%10.71B
173.82%20.23B
135.43%1.38B
-47.44%-27.33B
Change In working capital
-196.52%-11.26B
326.67%9.1B
13.35%-8.85B
-129.48%-12.25B
-3,043.83%-9.68B
205.99%11.67B
-198.19%-4.02B
-639.67%-10.22B
41.12%-5.34B
97.22%-308M
-Change in receivables
----
----
----
-49.50%-16.27B
----
----
----
----
21.04%-10.89B
----
-Change in inventory
----
----
----
-55.72%-7.42B
----
----
----
----
-339.35%-4.77B
----
-Change in payables and accrued expense
----
----
----
47.32%7.59B
----
----
----
----
64.12%5.15B
----
-Change in other current liabilities
----
----
----
27.28%5.1B
----
----
----
----
54.37%4.01B
----
-Change in other working capital
----
----
----
-206.47%-1.24B
----
----
----
----
1,467.57%1.16B
----
Cash from discontinued investing activities
Operating cash flow
7.04%43.85B
76.73%50.5B
-51.99%14.31B
38.06%108.91B
34.50%9.55B
69.01%40.97B
19.26%28.58B
26.41%29.81B
43.43%78.89B
335.37%7.1B
Investing cash flow
Cash flow from continuing investing activities
-57.85%-20.9B
-123.27%-20.73B
159.52%3.96B
-76.15%-43.89B
-6.26%-14.72B
-166.94%-13.24B
-121.07%-9.29B
-248.56%-6.65B
21.16%-24.92B
32.78%-13.85B
Net PPE purchase and sale
-107.93%-12.12B
-78.12%-10.47B
-80.57%-8.47B
-112.47%-25.81B
-89.62%-9.41B
-80.43%-5.83B
-141.40%-5.88B
-208.75%-4.69B
-91.73%-12.15B
-142.12%-4.96B
Net intangibles purchase and sale
91.97%-385M
-139.24%-2.77B
-395.37%-535M
-402.11%-13.09B
-479.95%-7.03B
-382.01%-4.8B
-726.43%-1.16B
58.46%-108M
-148.29%-2.61B
-357.36%-1.21B
Net business purchase and sale
--0
----
----
--0
--0
--0
----
----
61.30%-7.08B
----
Net investment purchase and sale
-220.77%-8.4B
-203.33%-6.83B
802.33%12.97B
-61.68%-5B
385.55%1.72B
-255.84%-2.62B
-38.46%-2.25B
-1,353.54%-1.85B
47.99%-3.09B
-9,933.33%-602M
Cash from discontinued investing activities
Investing cash flow
-57.85%-20.9B
-123.27%-20.73B
159.52%3.96B
-76.15%-43.89B
-6.26%-14.72B
-166.94%-13.24B
-121.07%-9.29B
-248.56%-6.65B
21.16%-24.92B
32.78%-13.85B
Financing cash flow
Cash flow from continuing financing activities
7.22%-18.4B
232.52%16.68B
-27.94%-26.38B
-21.93%-63.16B
-31.92%-10.12B
-36.18%-19.83B
-20.69%-12.59B
-7.77%-20.62B
-103.18%-51.8B
-268.56%-7.67B
Net issuance payments of debt
-58.24%-413M
7,998.12%29.46B
33.68%-317M
39.08%-1.47B
-175.19%-355M
20.91%-261M
-52.87%-373M
71.96%-478M
-115.56%-2.41B
-101.07%-129M
Net common stock issuance
60.84%-2.41B
15.57%-7.45B
45.45%-2.84B
-24.24%-29.92B
-29.47%-9.76B
-32.92%-6.14B
-18.43%-8.82B
-16.13%-5.2B
-23.85%-24.09B
-0.36%-7.54B
Cash dividends paid
-16.03%-15.58B
--0
-55.73%-28.56B
-25.55%-31.77B
--0
-39.71%-13.43B
--0
-16.87%-18.34B
-17.60%-25.3B
--0
Net other financing activities
----
----
57.03%5.33B
----
----
----
----
23.97%3.39B
----
----
Cash from discontinued financing activities
Financing cash flow
7.22%-18.4B
232.52%16.68B
-27.94%-26.38B
-21.93%-63.16B
-31.92%-10.12B
-36.18%-19.83B
-20.69%-12.59B
-7.77%-20.62B
-103.18%-51.8B
-268.56%-7.67B
Net cash flow
Beginning cash position
144.84%52.82B
-57.66%6.32B
13.74%14.39B
18.04%12.65B
7.05%29.88B
-5.19%21.57B
13.08%14.94B
18.04%12.65B
-12.33%10.72B
-5.34%27.91B
Current changes in cash
-42.40%4.55B
593.05%46.46B
-418.62%-8.11B
-14.46%1.86B
-6.00%-15.28B
67.36%7.89B
-28.16%6.7B
0.08%2.55B
203.53%2.17B
24.40%-14.42B
Effect of exchange rate changes
-183.25%-348M
164.62%42M
116.73%44M
50.00%-119M
75.24%-209M
-5.64%418M
-129.82%-65M
-378.18%-263M
-140.27%-238M
-381.33%-844M
End cash Position
90.80%57.02B
144.84%52.82B
-57.66%6.32B
13.74%14.39B
13.74%14.39B
7.05%29.88B
-5.19%21.57B
13.08%14.94B
18.04%12.65B
18.04%12.65B
Free cash flow
3.31%31.35B
72.99%37.27B
-78.79%5.31B
9.17%70.01B
-841.92%-6.89B
51.60%30.34B
0.73%21.54B
14.71%25.01B
34.69%64.13B
117.41%928M
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.04%43.85B76.73%50.5B-51.99%14.31B38.06%108.91B34.50%9.55B69.01%40.97B19.26%28.58B26.41%29.81B43.43%78.89B335.37%7.1B
Net income from continuing operations 21.46%27.3B3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B
Operating gains losses ------------66.39%32.27B----------------19.23%19.39B----
Depreciation and amortization -14.85%2.15B306.29%8.85B69.52%2.91B27.86%9.41B47.03%2.99B23.71%2.53B33.07%2.18B4.18%1.72B22.19%7.36B-2.26%2.04B
Deferred tax 26.82%7.08B9.45%5.28B32.26%6.51B55.06%20.99B107.67%5.66B53.98%5.59B38.80%4.83B32.73%4.92B19.55%13.54B22.65%2.72B
Other non cash items 846.75%18.81B4.43%11.18B-99.42%118M-247.68%-2.04B-27.91%-34.96B-88.24%1.99B142.36%10.71B173.82%20.23B135.43%1.38B-47.44%-27.33B
Change In working capital -196.52%-11.26B326.67%9.1B13.35%-8.85B-129.48%-12.25B-3,043.83%-9.68B205.99%11.67B-198.19%-4.02B-639.67%-10.22B41.12%-5.34B97.22%-308M
-Change in receivables -------------49.50%-16.27B----------------21.04%-10.89B----
-Change in inventory -------------55.72%-7.42B-----------------339.35%-4.77B----
-Change in payables and accrued expense ------------47.32%7.59B----------------64.12%5.15B----
-Change in other current liabilities ------------27.28%5.1B----------------54.37%4.01B----
-Change in other working capital -------------206.47%-1.24B----------------1,467.57%1.16B----
Cash from discontinued investing activities
Operating cash flow 7.04%43.85B76.73%50.5B-51.99%14.31B38.06%108.91B34.50%9.55B69.01%40.97B19.26%28.58B26.41%29.81B43.43%78.89B335.37%7.1B
Investing cash flow
Cash flow from continuing investing activities -57.85%-20.9B-123.27%-20.73B159.52%3.96B-76.15%-43.89B-6.26%-14.72B-166.94%-13.24B-121.07%-9.29B-248.56%-6.65B21.16%-24.92B32.78%-13.85B
Net PPE purchase and sale -107.93%-12.12B-78.12%-10.47B-80.57%-8.47B-112.47%-25.81B-89.62%-9.41B-80.43%-5.83B-141.40%-5.88B-208.75%-4.69B-91.73%-12.15B-142.12%-4.96B
Net intangibles purchase and sale 91.97%-385M-139.24%-2.77B-395.37%-535M-402.11%-13.09B-479.95%-7.03B-382.01%-4.8B-726.43%-1.16B58.46%-108M-148.29%-2.61B-357.36%-1.21B
Net business purchase and sale --0----------0--0--0--------61.30%-7.08B----
Net investment purchase and sale -220.77%-8.4B-203.33%-6.83B802.33%12.97B-61.68%-5B385.55%1.72B-255.84%-2.62B-38.46%-2.25B-1,353.54%-1.85B47.99%-3.09B-9,933.33%-602M
Cash from discontinued investing activities
Investing cash flow -57.85%-20.9B-123.27%-20.73B159.52%3.96B-76.15%-43.89B-6.26%-14.72B-166.94%-13.24B-121.07%-9.29B-248.56%-6.65B21.16%-24.92B32.78%-13.85B
Financing cash flow
Cash flow from continuing financing activities 7.22%-18.4B232.52%16.68B-27.94%-26.38B-21.93%-63.16B-31.92%-10.12B-36.18%-19.83B-20.69%-12.59B-7.77%-20.62B-103.18%-51.8B-268.56%-7.67B
Net issuance payments of debt -58.24%-413M7,998.12%29.46B33.68%-317M39.08%-1.47B-175.19%-355M20.91%-261M-52.87%-373M71.96%-478M-115.56%-2.41B-101.07%-129M
Net common stock issuance 60.84%-2.41B15.57%-7.45B45.45%-2.84B-24.24%-29.92B-29.47%-9.76B-32.92%-6.14B-18.43%-8.82B-16.13%-5.2B-23.85%-24.09B-0.36%-7.54B
Cash dividends paid -16.03%-15.58B--0-55.73%-28.56B-25.55%-31.77B--0-39.71%-13.43B--0-16.87%-18.34B-17.60%-25.3B--0
Net other financing activities --------57.03%5.33B----------------23.97%3.39B--------
Cash from discontinued financing activities
Financing cash flow 7.22%-18.4B232.52%16.68B-27.94%-26.38B-21.93%-63.16B-31.92%-10.12B-36.18%-19.83B-20.69%-12.59B-7.77%-20.62B-103.18%-51.8B-268.56%-7.67B
Net cash flow
Beginning cash position 144.84%52.82B-57.66%6.32B13.74%14.39B18.04%12.65B7.05%29.88B-5.19%21.57B13.08%14.94B18.04%12.65B-12.33%10.72B-5.34%27.91B
Current changes in cash -42.40%4.55B593.05%46.46B-418.62%-8.11B-14.46%1.86B-6.00%-15.28B67.36%7.89B-28.16%6.7B0.08%2.55B203.53%2.17B24.40%-14.42B
Effect of exchange rate changes -183.25%-348M164.62%42M116.73%44M50.00%-119M75.24%-209M-5.64%418M-129.82%-65M-378.18%-263M-140.27%-238M-381.33%-844M
End cash Position 90.80%57.02B144.84%52.82B-57.66%6.32B13.74%14.39B13.74%14.39B7.05%29.88B-5.19%21.57B13.08%14.94B18.04%12.65B18.04%12.65B
Free cash flow 3.31%31.35B72.99%37.27B-78.79%5.31B9.17%70.01B-841.92%-6.89B51.60%30.34B0.73%21.54B14.71%25.01B34.69%64.13B117.41%928M
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-0.04%